Literature DB >> 20697966

Fulminant, non-antibiotic associated Clostridium difficile colitis following Salmonella gastroenteritis.

Stephanie A C Halvorson1, Andrea S Cedfeldt, Alan J Hunter.   

Abstract

In the last decade there has been increasing awareness of the virulence and changing epidemiology of Clostridium difficile (C. difficile). While the vast majority of clinical cases of C. difficile are associated with antimicrobial or nosocomial exposure, this syndrome has been well described in the absence of antibiotic use. We present an unusual case of fatal, non-antibiotic associated C. difficile colitis following Salmonella serotype Saintpaul gastroenteritis in a previously healthy young person. We review the typical risk factors for C. difficile colitis and fulminant disease. We also review the epidemiology of community-acquired C. difficile-associated disease (CA-CDAD) and highlight Salmonella infection as a potential risk factor for development of CA-CDAD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697966      PMCID: PMC3024100          DOI: 10.1007/s11606-010-1466-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  20 in total

1.  Pseudomembranous colitis due to Salmonella enterica serotype infantis.

Authors:  K Mönkemüller; I Patasiūte; F Walther; U Peitz; L C Fry; P Malfertheiner
Journal:  Endoscopy       Date:  2006-05       Impact factor: 10.093

2.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

3.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains.

Authors:  Frédéric Barbut; Dominique Decré; Valérie Lalande; Béatrice Burghoffer; Latifa Noussair; Anne Gigandon; Florence Espinasse; Laurent Raskine; Jérome Robert; Alain Mangeol; Catherine Branger; Jean-Claude Petit
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

5.  Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.

Authors:  Sandra Dial; J A Chris Delaney; Verena Schneider; Samy Suissa
Journal:  CMAJ       Date:  2006-09-26       Impact factor: 8.262

6.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

7.  Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-12-02       Impact factor: 17.586

8.  Diarrhea in elderly patients due to Clostridium difficile associated with Salmonella and Shigella infection.

Authors:  Joseph Grinblat; Avraham Weiss; Boris Grosman; Dror Dicker; Yichayaou Beloosesky
Journal:  Arch Gerontol Geriatr       Date:  2004 Nov-Dec       Impact factor: 3.250

9.  Severe Clostridium difficile colitis.

Authors:  M S Rubin; L E Bodenstein; K C Kent
Journal:  Dis Colon Rectum       Date:  1995-04       Impact factor: 4.585

Review 10.  Clostridium difficile-associated disease: new challenges from an established pathogen.

Authors:  Rebecca H Sunenshine; L Clifford McDonald
Journal:  Cleve Clin J Med       Date:  2006-02       Impact factor: 2.321

View more
  2 in total

1.  Detection of coexisting toxigenic Clostridium difficile and nontyphoidal Salmonella in a healthcare worker with diarrhea: A therapeutic dilemma.

Authors:  Amos Lal; Raul Davaro; Ajay Kumar Mishra; Kamal Kant Sahu; George M Abraham
Journal:  J Family Med Prim Care       Date:  2019-08-28

2.  Clostridioides difficile co-infection with Enterohemorrhagic Escherichia coli (EHEC)-a potentially fatal combination.

Authors:  Farah Deshmukh; Upasana Agrawal; Nancy Merrell
Journal:  IDCases       Date:  2020-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.